Menu Search
Equities

Straumann Holding AG

0QMV:LSE

Straumann Holding AG

Actions
  • Price (CHF)112.05
  • Today's Change1.14 / 1.03%
  • Shares traded1.34k
  • 1 Year change-8.27%
  • Beta--
Data delayed at least 20 minutes, as of Nov 25 2024 08:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.

  • Revenue in CHF (TTM)2.47bn
  • Net income in CHF307.19m
  • Incorporated2005
  • Employees11.15k
  • Location
    Straumann Holding AGPeter Merian-Weg 12BASEL 4002SwitzerlandCHE
  • Phone+41 619651111
  • Fax+41 619651101
  • Websitehttps://www.straumann.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.